U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
2 days ago · The Hindu
India
& newspaper;
Read Full Article →
Sourced From
The Hindu
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
Source: The Hindu — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: The Hindu — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.